CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $219,000 | +43.1% | 6,476 | -1.0% | 0.00% | – |
| Q1 2021 | $153,000 | -22.3% | 6,543 | -4.4% | 0.00% | – |
| Q4 2020 | $197,000 | +42.8% | 6,843 | 0.0% | 0.00% | – |
| Q3 2020 | $138,000 | -39.7% | 6,843 | -10.3% | 0.00% | – |
| Q2 2020 | $229,000 | +143.6% | 7,632 | +154.7% | 0.00% | – |
| Q1 2020 | $94,000 | -36.1% | 2,997 | -4.2% | 0.00% | – |
| Q4 2019 | $147,000 | +764.7% | 3,129 | +15.5% | 0.00% | – |
| Q3 2019 | $17,000 | -37.0% | 2,708 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | -27.0% | 2,708 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | +640.0% | 2,708 | +136.9% | 0.00% | – |
| Q4 2018 | $5,000 | -37.5% | 1,143 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | – | 1,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |